BFA
IRD

BlackRock Fund Advisors’s Opus Genetics IRD Stock Holding History

BlackRock Fund Advisors’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$8K Buy
118
+26
+28% +$2.12K ﹤0.01% 3996
2016
Q3 		$9K Buy
92
+10
+12% +$1.21K ﹤0.01% 3983
2016
Q2 		$10K Buy
82
+6
+8% +$841 ﹤0.01% 3995
2016
Q1 		$12K Buy
76
+15
+25% +$2.5K ﹤0.01% 3952
2015
Q4 		$11K Buy
+61
New +$13K ﹤0.01% 4011

Other funds holding IRD

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HVIA
Hudson Valley Investment Advisors Goshen, New York $823M AUM 31.4% 1-Year Est. Return
NFC
Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BlackRock Fund Advisors's IRD Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Opus Genetics (IRD) stake by 28% in Q4 2016, buying an estimated $2.12K and bringing the position to 118 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #3996.

BlackRock Fund Advisors first reported a position in IRD in Q4 2015 and has held it in 5 quarters since. The position peaked at $12K in Q1 2016. 31 funds tracked by Wall St. Rank hold IRD as of Q4 2016.

  • BlackRock Fund Advisors held 118 shares of Opus Genetics worth $8K as of Q4 2016.
  • BlackRock Fund Advisors bought 26 Opus Genetics shares in Q4 2016, an estimated $2.12K.
  • Opus Genetics made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3996 holding.
  • BlackRock Fund Advisors first reported a position in Opus Genetics in Q4 2015 and has held it in 5 quarters since.
  • BlackRock Fund Advisors's Opus Genetics position peaked at $12K in Q1 2016.
  • 31 funds tracked by Wall St. Rank held Opus Genetics as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.